510(k) K161364
K161364 is an FDA 510(k) premarket notification submitted by Alere Scarborough, Inc. for the device "BinaxNOW G6PD Test". The FDA issued a decision of Substantially Equivalent on June 17, 2016. The device falls under product code JBF (Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening), a Class II device regulated under 21 CFR 864.7360. Alere Scarborough, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 17, 2016
- Date Received
- May 17, 2016
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening
- Device Class
- Class II
- Regulation Number
- 864.7360
- Review Panel
- HE
- Submission Type